PTX
Click for more information
5.00% 4.2¢ prescient therapeutics limited

The PTX-100 trial was updated on the Clinicaltrials.gov website...

  1. megamutts
    711 Posts.
    lightbulb Created with Sketch. 274
    clock Created with Sketch.
    17/12/20
    09:54
    Post #: 49642571
    The PTX-100 trial was updated on the Clinicaltrials.gov website yesterday

    New expected study completion date is 31 April

    This time line obviously aligns with what SYC has been saying, with expected results around Q2, including most recently at the AGM

    https://clinicaltrials.gov/ct2/history/NCT03900442?A=6&B=7&C=Side-by-Side#StudyPageTop
    Last edited by megamutts: 17/12/20
    PTX Price at posting: 6.2¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 18  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.2¢ 		Change
0.002(5.00%) 		Mkt cap ! $33.01M
Open High Low Value Volume
4.2¢ 4.2¢ 4.1¢ $1.134K 27.05K

Buyers (Bids)

No. Vol. Price($)
1 242158 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 102692 2
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.